Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Sep 12, 2023	SC TO-T/A	Amendment to a previously filed SC TO-T	View HTML 0001104659-23-100041.pdf 0001104659-23-100041.xls
Sep 08, 2023	SC TO-T/A	Amendment to a previously filed SC TO-T	View HTML 0001104659-23-099290.pdf 0001104659-23-099290.xls
Sep 08, 2023	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-23-099345.pdf 0001104659-23-099345.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Sep 08, 2023	8-K/A	Amendment to a previously filed 8-K	View HTML 0001104659-23-099351.pdf 0001104659-23-099351.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Sep 06, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-23-000033.pdf 0001968202-23-000033.xls
Sep 01, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-23-003620.pdf 0001950047-23-003620.xls
Aug 25, 2023	SC TO-T	Tender offer schedule and amendment filed by a third party.	View HTML 0001104659-23-095116.pdf 0001104659-23-095116.xls
Aug 25, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-23-000030.pdf 0001968202-23-000030.xls
Aug 25, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-23-000028.pdf 0001968202-23-000028.xls
Aug 25, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-23-000029.pdf 0001968202-23-000029.xls

Data provided by Kaleidoscope.

Investors & Media